Wnt/β-catenin signaling in cancers and targeted therapies
F Yu, C Yu, F Li, Y Zuo, Y Wang, L Yao, C Wu… - … and Targeted Therapy, 2021 - nature.com
Wnt/β-catenin signaling has been broadly implicated in human cancers and experimental
cancer models of animals. Aberrant activation of Wnt/β-catenin signaling is tightly linked with …
cancer models of animals. Aberrant activation of Wnt/β-catenin signaling is tightly linked with …
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
JM Lemée, A Clavreul, P Menei - Neuro-oncology, 2015 - academic.oup.com
Glioblastoma (GB) is the most frequent and aggressive primary tumor of the central nervous
system. Prognosis remains poor despite ongoing progress. In cases where the gadolinium …
system. Prognosis remains poor despite ongoing progress. In cases where the gadolinium …
STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models
G Berger, EH Knelson… - Proceedings of the …, 2022 - National Acad Sciences
Immunotherapy has had a tremendous impact on cancer treatment in the past decade, with
hitherto unseen responses at advanced and metastatic stages of the disease. However, the …
hitherto unseen responses at advanced and metastatic stages of the disease. However, the …
Lithium and therapeutic targeting of GSK-3
ME Snitow, RS Bhansali, PS Klein - Cells, 2021 - mdpi.com
Lithium salts have been in the therapeutic toolbox for better or worse since the 19th century,
with purported benefit in gout, hangover, insomnia, and early suggestions that lithium …
with purported benefit in gout, hangover, insomnia, and early suggestions that lithium …
Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1
Extracellular vesicles have emerged as important mediators of intercellular communication
in cancer, including by conveying tumor-promoting microRNAs between cells, but their …
in cancer, including by conveying tumor-promoting microRNAs between cells, but their …
Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target
The aryl hydrocarbon receptor (AHR) is highly expressed in multiple organs and tissues,
and there is increasing evidence that the AHR plays an important role in cellular …
and there is increasing evidence that the AHR plays an important role in cellular …
Glycogen synthase kinase‐3β is a pivotal mediator of cancer invasion and resistance to therapy
T Domoto, IV Pyko, T Furuta, K Miyashita… - Cancer …, 2016 - Wiley Online Library
Tumor cell invasion and resistance to therapy are the most intractable biological
characteristics of cancer and, therefore, the most challenging for current cancer research …
characteristics of cancer and, therefore, the most challenging for current cancer research …
Astrocytes promote glioma invasion via the gap junction protein connexin43
WC Sin, Q Aftab, JF Bechberger, JH Leung, H Chen… - Oncogene, 2016 - nature.com
Reactive astrocytes are integral to the glioma microenvironment. Connexin43 (Cx43) is a
major gap junction protein in astrocytes and its expression is enhanced significantly in …
major gap junction protein in astrocytes and its expression is enhanced significantly in …
Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship
H Wang, Z Wang, C Wei, J Wang, Y Xu, G Bai… - European Journal of …, 2021 - Elsevier
Indirubin is the crucial ingredient of Danggui Longhui Wan and Qing-Dai, traditional
Chinese medicine herbal formulas used for the therapy of chronic myelocytic leukemia in …
Chinese medicine herbal formulas used for the therapy of chronic myelocytic leukemia in …
CD73 promotes glioblastoma pathogenesis and enhances its chemoresistance via A2B adenosine receptor signaling
A Yan, ML Joachims, LF Thompson… - Journal of …, 2019 - Soc Neuroscience
Glioblastoma (GB) is one of the deadliest brain cancers to afflict humans, and it has a very
poor survival rate even with treatment. The extracellular adenosine-generating enzyme …
poor survival rate even with treatment. The extracellular adenosine-generating enzyme …